1. Home
  2. KALV vs CURV Comparison

KALV vs CURV Comparison

Compare KALV & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$15.51

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Logo Torrid Holdings Inc.

CURV

Torrid Holdings Inc.

HOLD

Current Price

$1.08

Market Cap

185.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
CURV
Founded
N/A
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
185.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KALV
CURV
Price
$15.51
$1.08
Analyst Decision
Strong Buy
Hold
Analyst Count
6
6
Target Price
$27.17
$1.59
AVG Volume (30 Days)
1.1M
488.5K
Earning Date
11-10-2025
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,426,000.00
$1,039,486,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$204.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.30
$0.94
52 Week High
$17.30
$7.19

Technical Indicators

Market Signals
Indicator
KALV
CURV
Relative Strength Index (RSI) 52.76 46.92
Support Level $14.83 $0.96
Resistance Level $16.30 $1.08
Average True Range (ATR) 0.89 0.09
MACD -0.15 0.01
Stochastic Oscillator 30.00 53.46

Price Performance

Historical Comparison
KALV
CURV

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.

Share on Social Networks: